Christopher J Jemapete Gene Biotherapeutics, Inc. (CRXM) insider trading activity

CRXM Quotes by TradingView

Christopher J Jemapete is > 10% Shareholder of Gene Biotherapeutics, Inc.. Currently has a direct ownership of 4 Million shares of CRXM, which is worth approximately $0. The most recent transaction as insider was on Mar 17, 2021, when has been sold 200,000 shares (Common Stock) at a price of $0.4 per share, resulting in proceeds of $80,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4M
0% 3M change
0% 12M change
Total Value Held $0

Christopher J Jemapete Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2021
BUY
Open market or private purchase
$80,000 $0.4 p/Share
200,000 Added 4.76%
4,000,000 Common Stock
Mar 16 2021
BUY
Open market or private purchase
$12,000 $0.04 p/Share
300,000 Added 7.32%
3,800,000 Common Stock
CJJ

Christopher J Jemapete

> 10% Shareholder
Aurora, CO

Track Institutional and Insider Activities on CRXM

Follow Gene Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRXM shares.

Notify only if

Insider Trading

Get notified when an Gene Biotherapeutics, Inc. insider buys or sells CRXM shares.

Notify only if

News

Receive news related to Gene Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRXM